Alyeska Investment Group’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Hold |
933,475
| – | – | 0.01% | 475 |
|
|
2025
Q1 | $3.16M | Hold |
933,475
| – | – | 0.01% | 389 |
|
|
2024
Q4 | $3.85M | Buy |
933,475
+433,475
| +87% | +$1.79M | 0.01% | 414 |
|
|
2024
Q3 | $1.25M | Hold |
500,000
| – | – | 0.01% | 450 |
|
|
2024
Q2 | $1.32M | Buy |
+500,000
| New | +$1.32M | 0.01% | 424 |
|
|
2016
Q3 | – | Sell |
-1,989
| Closed | -$1.78M | – | 460 |
|
|
2016
Q2 | $1.78M | Buy |
1,989
+40
| +2% | +$35.7K | 0.02% | 362 |
|
|
2016
Q1 | $1.77M | Buy |
1,949
+395
| +25% | +$359K | 0.02% | 333 |
|
|
2015
Q4 | $2.2M | Sell |
1,554
-529
| -25% | -$748K | 0.02% | 294 |
|
|
2015
Q3 | $3.49M | Buy |
2,083
+191
| +10% | +$320K | 0.04% | 286 |
|
|
2015
Q2 | $4.08M | Buy |
1,892
+138
| +8% | +$297K | 0.05% | 276 |
|
|
2015
Q1 | $3.21M | Buy |
1,754
+129
| +8% | +$236K | 0.04% | 302 |
|
|
2014
Q4 | $3.88M | Sell |
1,625
-60
| -4% | -$143K | 0.07% | 277 |
|
|
2014
Q3 | $4.13M | Buy |
+1,685
| New | +$4.13M | 0.09% | 227 |
|